BrightSpring Ebit Per Revenue vs Cost Of Revenue Analysis

BTSGU Stock

71.13 1.98 2.86%

BrightSpring Health financial indicator trend analysis is way more than just evaluating BrightSpring Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BrightSpring Health is a good investment. Please check the relationship between BrightSpring Health Ebit Per Revenue and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightSpring Health Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Ebit Per Revenue vs Cost Of Revenue

Ebit Per Revenue vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BrightSpring Health Ebit Per Revenue account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between BrightSpring Health's Ebit Per Revenue and Cost Of Revenue is -0.23. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of BrightSpring Health Services,, assuming nothing else is changed. The correlation between historical values of BrightSpring Health's Ebit Per Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of BrightSpring Health Services, are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebit Per Revenue i.e., BrightSpring Health's Ebit Per Revenue and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.23

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ebit Per Revenue

Cost Of Revenue

Cost of Revenue is found on BrightSpring Health income statement and represents the costs associated with goods and services BrightSpring Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from BrightSpring Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BrightSpring Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightSpring Health Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Tax Provision is likely to gain to about (17.6 M) in 2024. Selling General Administrative is likely to drop to about 1.2 B in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	233.6M	324.6M	373.3M	237.2M
Depreciation And Amortization	204.0M	202.3M	232.7M	216.4M

Interest Expense Depreciation And Amortization

BrightSpring Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Total Assets		0.99	0.87	0.92	-0.64	0.95	0.49	0.99	-0.67	0.92	-0.95	0.99	0.73	-0.67	0.99	-0.95	0.95	0.98	0.95	0.99	0.88	0.9	0.99	0.95	1.0	0.99
Short Long Term Debt Total	0.99		0.88	0.9	-0.59	0.96	0.41	1.0	-0.63	0.9	-0.96	0.99	0.68	-0.63	1.0	-0.96	0.93	0.99	0.97	0.99	0.91	0.86	0.96	0.97	0.99	0.99
Other Current Liab	0.87	0.88		0.94	-0.77	0.96	0.43	0.86	-0.76	0.88	-0.78	0.83	0.75	-0.57	0.87	-0.78	0.92	0.86	0.81	0.81	0.93	0.72	0.8	0.81	0.89	0.83
Total Current Liabilities	0.92	0.9	0.94		-0.8	0.92	0.67	0.9	-0.84	0.99	-0.85	0.86	0.83	-0.55	0.9	-0.85	0.99	0.89	0.86	0.86	0.81	0.9	0.89	0.86	0.94	0.85
Total Stockholder Equity	-0.64	-0.59	-0.77	-0.8		-0.71	-0.73	-0.56	0.96	-0.77	0.49	-0.52	-0.97	0.73	-0.58	0.49	-0.78	-0.53	-0.46	-0.55	-0.61	-0.68	-0.66	-0.46	-0.67	-0.53
Property Plant And Equipment Net	0.95	0.96	0.96	0.92	-0.71		0.4	0.94	-0.69	0.88	-0.86	0.93	0.74	-0.69	0.95	-0.86	0.93	0.93	0.88	0.93	0.97	0.78	0.92	0.88	0.96	0.94
Current Deferred Revenue	0.49	0.41	0.43	0.67	-0.73	0.4		0.41	-0.77	0.73	-0.38	0.36	0.74	-0.35	0.43	-0.38	0.67	0.39	0.36	0.42	0.18	0.79	0.57	0.36	0.54	0.36
Net Debt	0.99	1.0	0.86	0.9	-0.56	0.94	0.41		-0.62	0.9	-0.98	0.99	0.66	-0.59	1.0	-0.98	0.93	1.0	0.98	0.98	0.88	0.87	0.95	0.98	0.99	0.99
Retained Earnings	-0.67	-0.63	-0.76	-0.84	0.96	-0.69	-0.77	-0.62		-0.83	0.61	-0.57	-0.97	0.65	-0.63	0.61	-0.82	-0.6	-0.56	-0.59	-0.56	-0.75	-0.67	-0.56	-0.71	-0.57
Accounts Payable	0.92	0.9	0.88	0.99	-0.77	0.88	0.73	0.9	-0.83		-0.87	0.86	0.82	-0.54	0.9	-0.87	0.99	0.89	0.87	0.87	0.75	0.95	0.91	0.87	0.95	0.86
Cash	-0.95	-0.96	-0.78	-0.85	0.49	-0.86	-0.38	-0.98	0.61	-0.87		-0.97	-0.63	0.55	-0.97	1.0	-0.88	-0.98	-0.99	-0.95	-0.8	-0.86	-0.91	-0.99	-0.94	-0.96
Non Current Assets Total	0.99	0.99	0.83	0.86	-0.52	0.93	0.36	0.99	-0.57	0.86	-0.97		0.63	-0.63	1.0	-0.97	0.89	0.99	0.97	1.0	0.89	0.85	0.96	0.97	0.98	1.0
Non Currrent Assets Other	0.73	0.68	0.75	0.83	-0.97	0.74	0.74	0.66	-0.97	0.82	-0.63	0.63		-0.8	0.68	-0.63	0.83	0.63	0.57	0.66	0.63	0.77	0.75	0.57	0.75	0.63
Other Assets	-0.67	-0.63	-0.57	-0.55	0.73	-0.69	-0.35	-0.59	0.65	-0.54	0.55	-0.63	-0.8		-0.62	0.55	-0.59	-0.55	-0.47	-0.67	-0.68	-0.56	-0.72	-0.47	-0.65	-0.65
Long Term Debt	0.99	1.0	0.87	0.9	-0.58	0.95	0.43	1.0	-0.63	0.9	-0.97	1.0	0.68	-0.62		-0.97	0.93	0.99	0.97	0.99	0.89	0.87	0.96	0.97	0.99	0.99
Cash And Short Term Investments	-0.95	-0.96	-0.78	-0.85	0.49	-0.86	-0.38	-0.98	0.61	-0.87	1.0	-0.97	-0.63	0.55	-0.97		-0.88	-0.98	-0.99	-0.95	-0.8	-0.86	-0.91	-0.99	-0.94	-0.96
Net Receivables	0.95	0.93	0.92	0.99	-0.78	0.93	0.67	0.93	-0.82	0.99	-0.88	0.89	0.83	-0.59	0.93	-0.88		0.92	0.89	0.9	0.82	0.93	0.93	0.89	0.97	0.89
Good Will	0.98	0.99	0.86	0.89	-0.53	0.93	0.39	1.0	-0.6	0.89	-0.98	0.99	0.63	-0.55	0.99	-0.98	0.92		0.99	0.98	0.87	0.86	0.93	0.99	0.98	0.99
Common Stock Shares Outstanding	0.95	0.97	0.81	0.86	-0.46	0.88	0.36	0.98	-0.56	0.87	-0.99	0.97	0.57	-0.47	0.97	-0.99	0.89	0.99		0.95	0.82	0.84	0.9	1.0	0.95	0.97
Non Current Liabilities Total	0.99	0.99	0.81	0.86	-0.55	0.93	0.42	0.98	-0.59	0.87	-0.95	1.0	0.66	-0.67	0.99	-0.95	0.9	0.98	0.95		0.87	0.88	0.98	0.95	0.98	1.0
Capital Lease Obligations	0.88	0.91	0.93	0.81	-0.61	0.97	0.18	0.88	-0.56	0.75	-0.8	0.89	0.63	-0.68	0.89	-0.8	0.82	0.87	0.82	0.87		0.62	0.83	0.82	0.88	0.89
Inventory	0.9	0.86	0.72	0.9	-0.68	0.78	0.79	0.87	-0.75	0.95	-0.86	0.85	0.77	-0.56	0.87	-0.86	0.93	0.86	0.84	0.88	0.62		0.93	0.84	0.92	0.84
Other Current Assets	0.99	0.96	0.8	0.89	-0.66	0.92	0.57	0.95	-0.67	0.91	-0.91	0.96	0.75	-0.72	0.96	-0.91	0.93	0.93	0.9	0.98	0.83	0.93		0.9	0.98	0.96
Other Stockholder Equity	0.95	0.97	0.81	0.86	-0.46	0.88	0.36	0.98	-0.56	0.87	-0.99	0.97	0.57	-0.47	0.97	-0.99	0.89	0.99	1.0	0.95	0.82	0.84	0.9		0.95	0.96
Total Liab	1.0	0.99	0.89	0.94	-0.67	0.96	0.54	0.99	-0.71	0.95	-0.94	0.98	0.75	-0.65	0.99	-0.94	0.97	0.98	0.95	0.98	0.88	0.92	0.98	0.95		0.98
Net Invested Capital	0.99	0.99	0.83	0.85	-0.53	0.94	0.36	0.99	-0.57	0.86	-0.96	1.0	0.63	-0.65	0.99	-0.96	0.89	0.99	0.97	1.0	0.89	0.84	0.96	0.96	0.98

Click cells to compare fundamentals

BrightSpring Health Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BrightSpring Stock Analysis

When running BrightSpring Health's price analysis, check to measure BrightSpring Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightSpring Health is operating at the current time. Most of BrightSpring Health's value examination focuses on studying past and present price action to predict the probability of BrightSpring Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightSpring Health's price. Additionally, you may evaluate how the addition of BrightSpring Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BrightSpring Ebit Per Revenue vs Cost Of Revenue Analysis

Ebit Per Revenue vs Cost Of Revenue

Ebit Per Revenue vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebit Per Revenue

Cost Of Revenue

BrightSpring Health fundamental ratios Correlations

BrightSpring Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BrightSpring Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Net Debt
Good Will	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash

Other Stockholder Equity	- 0.99	Cash And Short Term Investments
Common Stock Shares Outstanding	- 0.99	Cash And Short Term Investments
Other Stockholder Equity	- 0.99	Cash
Common Stock Shares Outstanding	- 0.99	Cash
Good Will	- 0.98	Cash And Short Term Investments
Good Will	- 0.98	Cash